Resmed RMD
NYSE RMD
$231.52 +3.08 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Resmed (RMD) Profit After Tax Growth (3y) (2012 - 2026)

Resmed (RMD) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 21.98%
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 3.48%
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 18.63%
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -0.24%
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -34.07%
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -67.40%
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 43.54%
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -1.06%

Historic Data

Download Data
DateValue
Jun 30, 2026 18.63%
Mar 31, 2026 19.70%
Dec 31, 2025 20.40%
Sep 30, 2025 18.31%
Jun 30, 2025 24.86%
Mar 31, 2025 26.81%
Dec 31, 2024 19.54%
Sep 30, 2024 15.21%
Jun 30, 2024 14.42%
Mar 31, 2024 79.97%
Dec 31, 2023 5.17%
Sep 30, 2023 7.15%
Jun 30, 2023 8.90%
Mar 31, 2023 12.54%
Dec 31, 2022 11.89%
Sep 30, 2022 20.55%
Jun 30, 2022 41.53%
Mar 31, 2022 19.30%
Dec 31, 2021 17.41%
Sep 30, 2021 24.41%